Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GenMark Diagnostics Inc. GNMK

Healthcare
GenMark Diagnostics Inc is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The company currently operates in one reportable business segment, which encompasses the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary... see more

Recent & Breaking News (NDAQ:GNMK)

BREAKING NEWS ALERT: Halper Sadeh LLP Continues to Investigate PRAH, RMBL, GNMK, FLIR; Shareholders Are Encouraged to Contact the Firm

ACCESSWIRE IA March 20, 2021

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of GenMark Diagnostics, Inc. - GNMK

PR Newswire March 19, 2021

STOCK ALERT: Halper Sadeh LLP Investigates RMBL, STAY, GNMK, TPCO; Shareholders Are Encouraged to Contact the Firm

GlobeNewswire March 18, 2021

GENMARK INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GenMark Diagnostics - GNMK

Business Wire March 17, 2021

Advanced Tech COVID Testing Accuracy Set to Bring Successful Reopening of Economies

Livemoney March 17, 2021

INVESTIGATION ALERT: Halper Sadeh LLP Investigates STAY, GNMK, RMBL, FI, NTEC; Shareholders are Encouraged to Contact the Firm

PR Newswire March 16, 2021

Moore Kuehn Encourages SLGG, GNMK, STAY, and NBLX Investors to Contact Law Firm

PR Newswire March 16, 2021

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of GenMark Diagnostics (Nasdaq - GNMK)

ACCESSWIRE IA March 15, 2021

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of GenMark Diagnostics, Inc. Buyout

GlobeNewswire March 15, 2021

SHAREHOLDER ALERT: WeissLaw LLP Investigates GenMark Diagnostics, Inc.

PR Newswire March 15, 2021

GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.

GlobeNewswire March 15, 2021

GENMARK ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of GNMK and Encourages Investors to Contact the Firm

GlobeNewswire March 15, 2021

GenMark Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GenMark Diagnostics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - GNMK

Business Wire March 15, 2021

GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results

GlobeNewswire February 25, 2021

GenMark ePlex® RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis

GlobeNewswire February 22, 2021

GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference

GlobeNewswire February 16, 2021

Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels

GlobeNewswire February 16, 2021

GenMark Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

GlobeNewswire February 11, 2021

GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020

GlobeNewswire January 11, 2021

GenMark Diagnostics to Participate in Upcoming Investor Conferences

GlobeNewswire December 28, 2020